Lineage Cell Therapeutics Inc. (LCTX) at a glance
Lineage Cell Therapeutics Inc. (LCTX) is a small-cap Healthcare company. It trades at $1.11, with a 99% profit margin and revenue growth of 14.8%. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Value (65/100) and its weakest is Momentum (20/100). It carries above-market volatility, so expect larger swings.
- Price
- $1.12
- Market cap
- $316.6M
- P/E ratio
- n/a
- Dividend yield
- None
- Beta
- 1.51
- 52-week range
- $1.00 to $2.09
Value
65
Growth
60
Income
40
Safety
24
Momentum
20
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield